What has NICE said?
Sofosbuvir (also known as Sovaldi) is recommended as a possible treatment for adults with some types (called genotypes) of chronic hepatitis C. It is taken with other drugs (peginterferon alfa and ribavirin, or ribavirin alone). See table 1.
Table 1 Sofosbuvir treatment
Type of hepatitis C |
Sofosbuvir with peginterferon alfa and ribavirin |
Sofosbuvir with ribavirin alone |
Genotype 1 |
Recommended by NICE |
Not recommended by NICE |
Genotype 2 |
Recommended only if:
|
|
Genotype 3 |
Recommended only if:
|
Recommended only if the person has cirrhosis and cannot have interferon. |
Recommended only if the person has cirrhosis. |
Not recommended by NICE |
What does this mean for me?
If sofosbuvir (with peginterferon alfa and ribavirin, or ribavirin alone) is recommended for you and your doctor thinks that it is the right treatment, you should be able to have the treatment on the NHS.
If you are not eligible for treatment as described above, you should be able to continue taking sofosbuvir (with peginterferon alfa and ribavirin, or ribavirin alone) until you and your doctor decide it is the right time to stop.